Join
Live feed
·
PRReleasevia Quantisnow
Acer Therapeutics Inc. logo
Zevra Therapeutics Inc. logo

Zevra Therapeutics to Acquire Acer Therapeutics, Expanding its Rare Disease Portfolio and Adding Commercial Product

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACER (Acer Therapeutics Inc.), ZVRA (Zevra Therapeutics Inc.) and more on Quantisnow.